Riskpilot← Back to searchSign inGet full accessNordic Vascular Specialists AB
ABActiveOrg 5569103111Betonggatan 12Medical specialists activities · NACE 8622Est. 201219 employees
Revenue 2024
SEK 22,9M
+24% vs 2023
EBITDA margin
12.7%
+1026% vs 2023
Equity ratio
62.2%
Financial strength
Net profit 2024
SEK 5,9M
-10% vs 2023
| Revenue | SEK 22,9M | +24% |
| EBITDA | SEK 2,9M | +1026% |
| Net profit | SEK 5,9M | -10% |
| Total assets | SEK 13,3M | -17% |
| Equity | SEK 8,3M | +20% |
| Employees | 19 | — |
Legal name
Nordic Vascular Specialists AB
Org number
5569103111
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
13 november 2012
Share capital
SEK 67 000
Employees
19 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Företaget skall tillhandahålla tjänster inom det medicinska området. Utredning, behandling och uppföljning av patienter som lider av perifer kärlsjukdom inkluderande kirurgisk och medicinsk behandling av åderbråck, kärlförträngningar och utvidgningar av blodkärl. Dessutom kommer företaget att bedriva utbildning, kursverksamhet, föreläsningar, författande och konsultationsverksamhet inom området perifera kärlsjukdomar. Tjänsterna kommer dels att tillhandahållas i egna lokaler men även såsom tillfällig konsultverksamhet åt andra företag och intressenter.
Address
Betonggatan 12
Email
thorark@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 19 276 | 20 358 | 20 607 | 18 428 | 22 852 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 5 078 | 4 041 | 2 236 | 258 | 2 905 |
| Depreciation & amort. | −298 | −310 | −289 | −631 | −821 |
| EBIT | 4 780 | 3 731 | 1 947 | −373 | 2 084 |
| Net financials | 858 | 898 | 3 980 | 4 710 | 4 755 |
| Profit before tax | 4 638 | 6 749 | 7 127 | 7 117 | 6 139 |
| Tax | −798 | −1 214 | −799 | −587 | −283 |
| Net profit | 3 840 | 5 535 | 6 328 | 6 530 | 5 856 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 12 277 | 16 454 | 15 303 | 16 131 | 13 331 |
| Equity | 4 209 | 5 944 | 7 372 | 6 902 | 8 294 |
| Long-term debt | 603 | 703 | 607 | 1 581 | 1 004 |
| Short-term debt | 3 484 | 3 946 | 2 664 | 5 768 | 2 153 |
| Total debt | 4 087 | 4 649 | 3 271 | 7 349 | 3 157 |
EBITDA margin
12.7%
This company
15.8%
Market median
-20% vs market
20202024
Equity ratio
62.2%
This company
38.2%
Market median
+63% vs market
20202024
Return on equity
70.6%
This company
18.4%
Market median
+284% vs market
20202024
Net profit margin
25.6%
This company
8.1%
Market median
+216% vs market
20202024
Asset turnover
1.71×
This company
1.12×
Market median
+53% vs market
20202024
Debt / equity
0.61×
This company
0.62×
Market median
+2% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AF | Audit | 2022 |
MH Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nordic Vascular Specialists AB 
Kirurgicentrum Skåne ABBoard members of Nordic Vascular Specialists AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Filip Lundberg | Audit | 0 companies |
| Maximilian Henrik Gabriel Löfström | Chief Executive Officer | 0 companies |
| Steinarr Björnsson | Board of Directors | 0 companies |
| Timothy Andrew Resch | Board of Directors | 0 companies |
| Thórarinn Kristmundsson | Chairman | 0 companies |
| Thordur Ægir Bjarnason | Board of Directors | 0 companies |